Plasma high-mobility group box 1 levels and prediction of outcome in patients with traumatic brain injury

Clinica Chimica Acta

Volumn 413, Issue 21-23, 2012, Pages 1737-1741

  Wang, Ke Yi ^a   Yu, Guo Feng ^b   Zhang, Zu Yong ^a   Huang, Qiang ^b   Dong, Xiao Qiao ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Quzhou People's Hospital   (China)

Author keywords

Functional outcome; High mobility group box 1; Mortality; Traumatic brain injury

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNCTIONAL STATUS; GLASGOW OUTCOME SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TRAUMATIC BRAIN INJURY;

ADULT; BIOLOGICAL MARKERS; BRAIN INJURIES; CASE-CONTROL STUDIES; GLASGOW OUTCOME SCALE; HMGB1 PROTEIN; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; ROC CURVE;

EID: 84864469515     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.07.002     Document Type: Article

References (36)

1. Landsman D., Bustin M.A. Signature for the HMG-1 box DNA binding proteins. Bioessays 1993, 15:539-546.
2. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 1999, 19:5237-5246.
3. Wang H., Bloom O., Zhang M., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
4. Abraham E., Arcaroli J., Carmody A., Wang H., Tracey K.J. HMG-1 as a mediator of acute lung inflammation. J Immunol 2000, 165:2950-2954.
5. Lotze M.T., Tracey K.J. High-mobility group box 1 protein (hmgb1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005, 5:331-342.
6. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191-195.
7. Yang H., Ochani M., Li J., et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 2004, 101:296-301.
8. Ombrellino M., Wang H., Ajemian M.S., et al. Increased serum concentrations of high-mobility group protein 1 in haemorrhagic shock. Lancet 1999, 354:1446-1447.
9. Murakami K., Koide M., Dumont T.M., Russell S.R., Tranmer B.I., Wellman G.C. Subarachnoid hemorrhage induces gliosis and increased expression of the pro-inflammatory cytokine high mobility group box 1 protein. Transl Stroke Res 2011, 2:72-79.
10. Watanabe M., Miyajima M., Nakajima M., et al. Expression analysis of high mobility group box-1 protein (HMGB-1) in the cerebral cortex, hippocampus, and cerebellum of the congenital hydrocephalus (H-Tx) rat. Acta Neurochir Suppl 2012, 113:91-96.
11. Guazzi S., Strangio A., Franzi A.T., Bianchi M.E. HMGB1, an architectural chromatin protein and an extracellular signaling factor, has a spatially and temporally restricted expression pattern in mouse brain. Gene Expr Patterns 2003, 3:29-33.
12. Agnello D., Wang H., Yang H., Tracey K.J., Ghezzi P. HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine 2002, 18:231-236.
13. Wang H., Vishnubhakat J.M., Bloom O., et al. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 1999, 126:389-392.
14. Qiu J., Nishimura M., Wang Y., et al. Early release of hmgb-1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab 2008, 28:927-938.
15. Tang D., Kang R., Cao L., et al. A pilot study to detect high mobility group box 1 and heat shock protein 72 in cerebrospinal fluid of pediatric patients with meningitis. Crit Care Med 2008, 36:291-295.
16. Vogelgesang A., May V.E., Grunwald U., et al. Functional status of peripheral blood T-cells in ischemic stroke patients. PLoS One 2010, 5:e8718.
17. Goldstein R.S., Gallowitsch-Puerta M., Yang L., et al. Elevated high-mobility group box 1 concentrations in patients with cerebral and myocardial ischemia. Shock 2006, 25:571-574.
18. King M.D., Laird M.D., Ramesh S.S., et al. Elucidating novel mechanisms of brain injury following subarachnoid hemorrhage: an emerging role for neuroproteomics. Neurosurg Focus 2010, 28:E10.
19. Nakahara T., Tsuruta R., Kaneko T., et al. High-mobility group box 1 protein in CSF of patients with subarachnoid hemorrhage. Neurocrit Care 2009, 11:362-368.
20. Zhou Y., Xiong K.L., Lin S., et al. Elevation of high-mobility group protein box-1 in serum correlates with severity of acute intracerebral hemorrhage. Mediators Inflamm 2010, pii: 142458.
21. Juul N., Morris G.F., Marshall S.B., Marshall L.F. Intracranial hypertension and cerebral perfusion pressure: influence on neurological deterioration and outcome in severe head injury. The Executive Committee of the International Selfotel Trial. J Neurosurg 2000, 92:1-6.
22. Laird A.M., Miller P.R., Kilgo P.D., Meredith J.W., Chang M.C. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma 2004, 56:1058-1062.
23. Van den Berghe G., Schoonheydt K., Becx P., Bruyninckx F., Wouters P.J. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005, 64:1348-1353.
24. Marshall L.F., Marshall S.B., Klauber M.R., Clark M.V. A new classification of head injury based on computerized tomography. J Neurosurg 1991, 75:S14-S20.
25. Moppett I.K. Traumatic brain injury. assessment, resuscitation and early management. Br J Anaesth 2007, 99:18-31.
26. Jennett B., Bond M. Assessment of outcome after severe brain damage. Lancet 1975, 1:480-484.
27. Thomas J.O., Travers A.A. HMG1 and 2, and related 'architectural' DNA-binding proteins. Trends Biochem Sci 2001, 26:167-174.
28. Kokkola R., Li J., Sundberg E., et al. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum 2003, 48:2052-2058.
29. Taniguchi N., Kawahara K., Yone K., et al. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 2003, 48:971-981.
30. Ueno H., Matsuda T., Hashimoto S., et al. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 2004, 170:1310-1316.
31. Tsung A., Sahai R., Tanaka H., et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005, 201:1135-1143.
32. Dumitriu I.E., Baruah P., Manfredi A.A., Bianchi M.E., Rovere-Querini P. HMGB1: guiding immunity from within. Trends Immunol 2005, 26:381-387.
33. Bianchi M.E., Manfredi A.A. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev 2007, 220:35-46.
34. Klune J.R., Dhupar R., Cardinal J., Billiar T.R., Tsung A. HMGB1: endogenous danger signaling. Mol Med 2008, 14:476-484.
35. Qiu J., Xu J., Zheng Y., et al. High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia. Stroke 2010, 41:2077-2082.
36. Muhammad S., Barakat W., Stoyanov S., et al. The HMGB1 receptor RAGE mediates ischemic brain damage. J Neurosci 2008, 28:12023-12031.